Acro Biomedical Co (ROCO:6748) Debt-to-Revenue : 0.34 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Acro Biomedical Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Acro Biomedical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$5.26 Mil. Acro Biomedical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$10.59 Mil. Acro Biomedical Co's annualized Revenue for the quarter that ended in Dec. 2024 was NT$46.37 Mil. Acro Biomedical Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.34.

Acro Biomedical Co Debt-to-Revenue Historical Data

The historical data trend for Acro Biomedical Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Debt-to-Revenue Chart

Acro Biomedical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Revenue

Get a 7-Day Free Trial

0.93

0.61

0.43

0.42

0.36

Acro Biomedical Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Debt-to-Revenue	Get a 7-Day Free Trial								0.38	0.71	0.31	0.44	0.34

Competitive Comparison of Acro Biomedical Co's Debt-to-Revenue

For the Biotechnology subindustry, Acro Biomedical Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acro Biomedical Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acro Biomedical Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's Debt-to-Revenue falls into.

Save Embed

;

Save Embed

;

Acro Biomedical Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Acro Biomedical Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(5.256	+	10.593)	/	44.232
	=	0.36

Acro Biomedical Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(5.256	+	10.593)	/	46.372
	=	0.34

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2024) Revenue data.

Acro Biomedical Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Acro Biomedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acro Biomedical Co Ltd (ROCO:6748) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

3rd Floor, No. 57, Luke 2nd Road, Luzhu District, Kaohsiung, TWN

Website

https://www.acrobiomedical.com

Acro Biomedical Co Ltd is a company whose technical team integrates the Research and development capabilities of Taiwan's major scientific research units and medical centers to jointly develop equipment for repairing organs and tissues in various parts of the human body. It mainly focuses on orthopedics, dentistry, cardiovascular specialists, ophthalmology, surgery, wound care, Medical equipment used in sports injuries and other specialties.

Acro Biomedical Co Headlines

No Headlines